Lotus Pharmaceuticals Operating Margin vs. Debt To Equity
| LTUS Stock | USD 0.01 0.0007 11.67% |
For Lotus Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Lotus Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Lotus Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Lotus Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Lotus Pharmaceuticals over time as well as its relative position and ranking within its peers.
Lotus |
Lotus Pharmaceuticals Debt To Equity vs. Operating Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Lotus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Lotus Pharmaceuticals is currently regarded as number one stock in operating margin category among its peers. It also is currently regarded as number one stock in debt to equity category among its peers fabricating about 0.54 of Debt To Equity per Operating Margin. The ratio of Operating Margin to Debt To Equity for Lotus Pharmaceuticals is roughly 1.85 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.Lotus Debt To Equity vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Lotus Pharmaceuticals |
| = | 0.11 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Lotus Pharmaceuticals |
| = | 0.06 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Lotus Debt To Equity Comparison
Lotus Pharmaceuticals is currently under evaluation in debt to equity category among its peers.
Lotus Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Lotus Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Lotus Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Lotus Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Lotus Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.
Lotus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Lotus Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Lotus Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Lotus Pharmaceuticals' important profitability drivers and their relationship over time.
Use Lotus Pharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lotus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Lotus Pharmaceuticals Pair Trading
Lotus Pharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Lotus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lotus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lotus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lotus Pharmaceuticals to buy it.
The correlation of Lotus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lotus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lotus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lotus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Lotus Pharmaceuticals position
In addition to having Lotus Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.